In order to be as transparent as possible regarding charges for COVID-19 testing, insurance and billing information is included below along with prices for COVID-19 testing currently available.

COVID-19 Insurance and Billing Information

For Medicare Patients and Patients with a Health Insurance Plan Regulated by the State of Maryland

There is no out-of-pocket expense. The visit will be submitted to your insurance plan, which should not charge you a deductible, coinsurance, or copay. We accept most major insurance plans, including Medicaid. You can contact your health insurance plan at the number on your identification card to find out whether your plan is regulated by the State of Maryland. Medicare also covers 100% of the cost of COVID-19 testing. 

Billing

For questions about your bill or to make a payment, please call 410-821-4140.

Charges

Below are the prices for COVID-19 testing currently available.

  • Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome Coronavirus 2 (SSARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique (CPT 87635/U0002): $51.31
  • Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies (CPT 87635/U0002): $51.31
  • 2019-nCoV Coronavirus, SARS-CoV coronavirus SARS-CoV-2/2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies (CPT 87635/U0002): $51.31
  • Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique (CPT 87636): $142.63
  • Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected (CPT 0241U): $142.63
  • Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected (CPT 0202U): $416.78
  • Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) (CPT 87426): $35.33
  • Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) (CPT 86769): $42.13